Search

everythinglearnresearchcommunity

for

Search:↓

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

PCOS and related metabolic issues often run in families.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

People with androgenetic alopecia are more likely to have metabolic syndrome.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

PCOS is linked to metabolic issues and infertility, needing more research.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Nutritional supplements may help improve hair growth in female pattern hair loss.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.